Meridian Bioscience: Fiscal 3Q Earnings Snapshot
CINCINNATI (AP) _ Meridian Bioscience Inc. (VIVO) on Tuesday reported fiscal third-quarter earnings of $5.1 million.
The Cincinnati-based company said it had profit of 12 cents per share. Earnings, adjusted for non-recurring costs, were 16 cents per share.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 10 cents per share.
The diagnostic test maker posted revenue of $48.4 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $49.8 million.
Meridian Bioscience expects full-year earnings in the range of 63 cents to 65 cents per share.
Meridian Bioscience shares have decreased 34% since the beginning of the year. The stock has dropped 26% in the last 12 months.